We are live on ! Find out more
DMIIR

Drugs Made In America Acquisition II Corp Right
DMIIR

57 hedge funds and large institutions have $3.25M invested in Drugs Made In America Acquisition II Corp Right in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 4

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

21% more funds holding

Funds holding: 47 → 57 (+10)

28% less capital invested

Capital invested by funds: $4.53M → $3.25M (-$1.28M)

Holders
57
Holders Change
+10
Holders Change %
+21.28%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
8
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MI
MMCAP International
Cayman Islands
+$307K
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$227K
3
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$121K
4
HCM
Highbridge Capital Management
New York
+$104K
5
MCS
Mercuria Capital Strategies
Texas
+$85.2K

Top Sellers

Rank Fund Capital Flow
1
FTCM
First Trust Capital Management
Illinois
-$290K
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$30K
3
SCM
Shaolin Capital Management
Florida
-$17K
4
QL
Quarry LP
New York
-$11.3K
5
HCI
Harraden Circle Investments
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
26
HBK Investments
Texas
$40K – – –
MC
27
Meteora Capital
Florida
$38.4K +$47.8K +420,604 +701%
WA
28
Whitebox Advisors
Minnesota
$36K – – –
HCM
29
Heights Capital Management
California
$34.3K +$48.7K +428,784 New
WC
30
Wealthspring Capital
New York
$32.2K -$713 -6,280 -2%
COPPSERS
31
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$32K – – –
RCM
32
Rivernorth Capital Management
Florida
$32K +$45.4K +400,000 New
SCM
33
Shaolin Capital Management
Florida
$30K -$17K -150,000 -29%
KC
34
Kryger Capital
United Kingdom
$29.3K +$41.5K +365,701 New
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$27.9K – – –
LPC
36
Lineage Point Capital
Florida
$26.4K – – –
AGM
37
Alpine Global Management
New York
$24K – – –
SAMU
38
SONA Asset Management (US)
New York
$24K – – –
PC
39
Periscope Capital
Ontario, Canada
$24K +$5.68K +50,000 +20%
BFM
40
Boothbay Fund Management
New York
$21.5K +$30.6K +269,202 New
KPF
41
K2 Principal Fund
Ontario, Canada
$20K – – –
MTCM
42
Mint Tower Capital Management
Netherlands
$20K – – –
Verition Fund Management
43
Verition Fund Management
Connecticut
$16K – – –
GCIA
44
Gabelli & Co Investment Advisers
New York
$14.4K +$20.4K +179,500 New
GF
45
Gabelli Funds
New York
$12.9K +$18.3K +161,400 New
JP Morgan Chase
46
JP Morgan Chase
New York
$12.6K – – –
CS
47
Clear Street
New York
$11.4K +$13.1K +115,712 +424%
DAM
48
DLD Asset Management
New York
$8.98K – – –
CCC
49
Cable Car Capital
California
$8K – – –
PEAK6
50
PEAK6
Illinois
$8K – – –
1
2
3

DMIIR Hedge Fund Activity: Q1 2026 in Review

57 of the 8,151 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Right (DMIIR) for Q1 2026, worth a combined $3.25M — down 28% from $4.53M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new DMIIR positions and 4 closed out — a net gain of 10 holders — while 8 added to existing stakes and 5 trimmed.

The largest buyer was MMCAP International, opening a new position worth an estimated $307K. The largest seller was First Trust Capital Management, exiting entirely with an estimated $290K sold.

  • 57 institutional investors held Drugs Made In America Acquisition II Corp Right (DMIIR) as of Q1 2026, up from 47 in Q4 2025.
  • Funds reported $3.25M of Drugs Made In America Acquisition II Corp Right stock for Q1 2026, down 28% quarter-over-quarter.
  • 14 funds opened new Drugs Made In America Acquisition II Corp Right positions in Q1 2026 and 4 closed out, a net change of +10 holders.
  • The largest Drugs Made In America Acquisition II Corp Right buyer in Q1 2026 was MMCAP International, an estimated $307K added.
  • The largest Drugs Made In America Acquisition II Corp Right seller in Q1 2026 was First Trust Capital Management, an estimated $290K sold.

Based on aggregated 13F filings for Q1 2026.